VRI Biomedical

Get notifications in MyBN when activity occurs. Upgrade your subscription to use this feature.

VRI Biomedical was a Perth-based listed company in the early 2000s after a $8.8 million raising. It floated on the ASX in 2000.
In 2005 it changed its name to Probiomics, reflecting the name of one of its products, and dual-listed on the London Stock Exchanges Alternative Investments Market (AIM). One of its areas of focus was a flu vaccine.
In 2012 it changed its name to Bioxyne as part of a takeover of Hunter Immunology.

Company Activity

Healthtech banks on rising numbers
NEWS: Tagged in Healthtech banks on rising numbers07 Nov 2022

News Articles

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options